Literature DB >> 21561773

Central carbon metabolism in Mycobacterium tuberculosis: an unexpected frontier.

Kyu Y Rhee1, Luiz Pedro Sorio de Carvalho, Ruslana Bryk, Sabine Ehrt, Joeli Marrero, Sae Woong Park, Dirk Schnappinger, Aditya Venugopal, Carl Nathan.   

Abstract

Recent advances in liquid chromatography and mass spectrometry have enabled the highly parallel, quantitative measurement of metabolites within a cell and the ability to trace their biochemical fates. In Mycobacterium tuberculosis (Mtb), these advances have highlighted major gaps in our understanding of central carbon metabolism (CCM) that have prompted fresh interpretations of the composition and structure of its metabolic pathways and the phenotypes of Mtb strains in which CCM genes have been deleted. High-throughput screens have demonstrated that small chemical compounds can selectively inhibit some enzymes of Mtb's CCM while sparing homologs in the host. Mtb's CCM has thus emerged as a frontier for both fundamental and translational research.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21561773      PMCID: PMC3601588          DOI: 10.1016/j.tim.2011.03.008

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  72 in total

Review 1.  Mass spectrometry in metabolome analysis.

Authors:  Silas G Villas-Bôas; Sandrine Mas; Mats Akesson; Jørn Smedsgaard; Jens Nielsen
Journal:  Mass Spectrom Rev       Date:  2005 Sep-Oct       Impact factor: 10.946

Review 2.  Carbon metabolism of intracellular bacteria.

Authors:  Ernesto J Muñoz-Elías; John D McKinney
Journal:  Cell Microbiol       Date:  2006-01       Impact factor: 3.715

3.  Mycobacterial bacilli are metabolically active during chronic tuberculosis in murine lungs: insights from genome-wide transcriptional profiling.

Authors:  Adel M Talaat; Sarah K Ward; Chia-Wei Wu; Elizabeth Rondon; Christine Tavano; John P Bannantine; Rick Lyons; Stephen A Johnston
Journal:  J Bacteriol       Date:  2007-03-23       Impact factor: 3.490

4.  Distribution of orphan metabolic activities.

Authors:  Lifeng Chen; Dennis Vitkup
Journal:  Trends Biotechnol       Date:  2007-06-18       Impact factor: 19.536

5.  Dihydrolipoamide acyltransferase is critical for Mycobacterium tuberculosis pathogenesis.

Authors:  Shuangping Shi; Sabine Ehrt
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

6.  Dual role of isocitrate lyase 1 in the glyoxylate and methylcitrate cycles in Mycobacterium tuberculosis.

Authors:  Ty A Gould; Helmus van de Langemheen; Ernesto J Muñoz-Elías; John D McKinney; James C Sacchettini
Journal:  Mol Microbiol       Date:  2006-08       Impact factor: 3.501

7.  Mycobacterium tuberculosis appears to lack alpha-ketoglutarate dehydrogenase and encodes pyruvate dehydrogenase in widely separated genes.

Authors:  Jing Tian; Ruslana Bryk; Shuangping Shi; Hediye Erdjument-Bromage; Paul Tempst; Carl Nathan
Journal:  Mol Microbiol       Date:  2005-08       Impact factor: 3.501

8.  Variant tricarboxylic acid cycle in Mycobacterium tuberculosis: identification of alpha-ketoglutarate decarboxylase.

Authors:  Jing Tian; Ruslana Bryk; Manabu Itoh; Makoto Suematsu; Carl Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-18       Impact factor: 11.205

9.  Diarylquinolines target subunit c of mycobacterial ATP synthase.

Authors:  Anil Koul; Najoua Dendouga; Karen Vergauwen; Brenda Molenberghs; Luc Vranckx; Rudy Willebrords; Zorica Ristic; Holger Lill; Ismet Dorange; Jerome Guillemont; Dirk Bald; Koen Andries
Journal:  Nat Chem Biol       Date:  2007-05-13       Impact factor: 15.040

10.  Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and proposing alternative drug targets.

Authors:  Neema Jamshidi; Bernhard Ø Palsson
Journal:  BMC Syst Biol       Date:  2007-06-08
View more
  72 in total

1.  Minding the gaps: metabolomics mends functional genomics.

Authors:  Kyu Rhee
Journal:  EMBO Rep       Date:  2013-10-01       Impact factor: 8.807

Review 2.  The tuberculosis drug discovery and development pipeline and emerging drug targets.

Authors:  Khisimuzi Mdluli; Takushi Kaneko; Anna Upton
Journal:  Cold Spring Harb Perspect Med       Date:  2015-01-29       Impact factor: 6.915

3.  Quantitative mass spectrometry reveals plasticity of metabolic networks in Mycobacterium smegmatis.

Authors:  Tarun Chopra; Romain Hamelin; Florence Armand; Diego Chiappe; Marc Moniatte; John D McKinney
Journal:  Mol Cell Proteomics       Date:  2014-07-05       Impact factor: 5.911

Review 4.  Updating and curating metabolic pathways of TB.

Authors:  Richard A Slayden; Mary Jackson; Jeremy Zucker; Melissa V Ramirez; Clinton C Dawson; Rebecca Crew; Nicole S Sampson; Suzanne T Thomas; Neema Jamshidi; Peter Sisk; Ron Caspi; Dean C Crick; Michael R McNeil; Martin S Pavelka; Michael Niederweis; Axel Siroy; Valentina Dona; Johnjoe McFadden; Helena Boshoff; Jocelyne M Lew
Journal:  Tuberculosis (Edinb)       Date:  2013-02-01       Impact factor: 3.131

5.  Methylcitrate cycle defines the bactericidal essentiality of isocitrate lyase for survival of Mycobacterium tuberculosis on fatty acids.

Authors:  Hyungjin Eoh; Kyu Y Rhee
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-17       Impact factor: 11.205

6.  Novel antibiotics targeting respiratory ATP synthesis in Gram-positive pathogenic bacteria.

Authors:  Wendy Balemans; Luc Vranckx; Nacer Lounis; Ovidiu Pop; Jérôme Guillemont; Karen Vergauwen; Selena Mol; Ron Gilissen; Magali Motte; David Lançois; Miguel De Bolle; Kristien Bonroy; Holger Lill; Koen Andries; Dirk Bald; Anil Koul
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

7.  Sample preparation of Mycobacterium tuberculosis extracts for nuclear magnetic resonance metabolomic studies.

Authors:  Denise K Zinniel; Robert J Fenton; Steven Halouska; Robert Powers; Raul G Barletta
Journal:  J Vis Exp       Date:  2012-09-03       Impact factor: 1.355

Review 8.  Fresh approaches to anti-infective therapies.

Authors:  Carl Nathan
Journal:  Sci Transl Med       Date:  2012-06-27       Impact factor: 17.956

9.  Acetate Dissimilation and Assimilation in Mycobacterium tuberculosis Depend on Carbon Availability.

Authors:  Nadine Rücker; Sandra Billig; René Bücker; Dieter Jahn; Christoph Wittmann; Franz-Christoph Bange
Journal:  J Bacteriol       Date:  2015-07-27       Impact factor: 3.490

10.  Ergothioneine Maintains Redox and Bioenergetic Homeostasis Essential for Drug Susceptibility and Virulence of Mycobacterium tuberculosis.

Authors:  Vikram Saini; Bridgette M Cumming; Loni Guidry; Dirk A Lamprecht; John H Adamson; Vineel P Reddy; Krishna C Chinta; James H Mazorodze; Joel N Glasgow; Melissa Richard-Greenblatt; Anaximandro Gomez-Velasco; Horacio Bach; Yossef Av-Gay; Hyungjin Eoh; Kyu Rhee; Adrie J C Steyn
Journal:  Cell Rep       Date:  2016-01-07       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.